These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16612309)

  • 21. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dobutamine does not influence inflammatory pathways during human endotoxemia.
    Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
    Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
    Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
    Tarhan OR; Barut I; Sezik M
    J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
    Agren A; Wiman B; Schulman S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of nafamostat mesilate on serum activities of pancreatic enzymes and plasma hormone levels].
    Wakayama S; Suzuki T; Sakai T; Matsuki A
    Masui; 1990 Jun; 39(6):734-40. PubMed ID: 2388392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7.
    Hagiwara S; Iwasaka H; Matumoto S; Noguchi T
    Shock; 2007 Apr; 27(4):429-35. PubMed ID: 17414427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAI-1 plays an important role in liver failure after excessive hepatectomy in the rat.
    Watanabe K; Togo S; Takahashi T; Matsuyama R; Yamamoto H; Shimizu T; Makino H; Matsuo K; Morioka D; Kubota T; Nagashima Y; Shimada H
    J Surg Res; 2007 Nov; 143(1):13-9. PubMed ID: 17655862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
    Harada N; Okajima K; Uchiba M
    Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells.
    Guimarães AH; Laurens N; Weijers EM; Koolwijk P; van Hinsbergh VW; Rijken DC
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2157-62. PubMed ID: 17673703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of T-686, an inhibitor of plasminogen activator inhibitor-1 production, against the lethal effect of lipopolysaccharide in mice.
    Murakami J; Ohtani A; Murata S
    Jpn J Pharmacol; 1997 Nov; 75(3):291-4. PubMed ID: 9434261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophils express tissue factor in a monkey model of sepsis.
    Todoroki H; Nakamura S; Higure A; Okamoto K; Takeda S; Nagata N; Itoh H; Ohsato K
    Surgery; 2000 Feb; 127(2):209-16. PubMed ID: 10686987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver tissue inducible nitric oxide synthase (iNOS) expression and lipid peroxidation in experimental hepatic ischemia reperfusion injury stimulated with lipopolysaccharide: the role of aminoguanidine.
    Yaylak F; Canbaz H; Caglikulekci M; Dirlik M; Tamer L; Ogetman Z; Polat Y; Kanik A; Aydin S
    J Surg Res; 2008 Aug; 148(2):214-23. PubMed ID: 18222473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periodontitis is characterized by elevated PAI-1 activity.
    Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG
    J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats.
    Chen CH; Lee RP; Wu WT; Liao KW; Hsu N; Hsu BG
    Resuscitation; 2007 Jul; 74(1):166-74. PubMed ID: 17353078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acupuncture stimulation of ST36 (Zusanli) attenuates acute renal but not hepatic injury in lipopolysaccharide-stimulated rats.
    Huang CL; Tsai PS; Wang TY; Yan LP; Xu HZ; Huang CJ
    Anesth Analg; 2007 Mar; 104(3):646-54. PubMed ID: 17312224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel approaches to thrombolysis based on modulation of endogenous fibrinolysis.
    Stefansson S; Lawrence DA; Herren T; Plow EF
    Coron Artery Dis; 1998; 9(2-3):99-104. PubMed ID: 9647410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.